A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.
Clinical trial NCT06421298 · RECRUITING
Trial details
- NCT number
- NCT06421298
- Sponsor
- Jinghui Wang
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2027-05-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.